MetaVia (MTVA) Payables (2015 - 2026)
MetaVia's (MTVA) quarterly Payables came in at $1.1 million in Q4 2025, down 72.67% YoY from $3.9 million in Q4 2024, and down 59.22% on a QoQ basis from $2.6 million in Q3 2025.
MetaVia (MTVA) Payables (2015 - 2026) Analysis & Trends
MetaVia (MTVA) has 11 years of Payables data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Payables fell 72.67% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 72.67% YoY) and the FY2025 annual result came in at $1.1 million, down 72.67% from the prior year.
- Payables retreated to $1.1 million in Q4 2025, from $2.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $3.9 million in Q4 2024 to a low of $347000.0 in Q2 2021.
- A 5-year average of $1.5 million and a median of $1.0 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables tumbled 79.38% — and 2024, when it surged 372.47%.
- Tracing MTVA's Payables over 5 years: stood at $830000.0 in 2021, then declined by 14.7% to $708000.0 in 2022, then increased by 15.96% to $821000.0 in 2023, then jumped by 372.47% to $3.9 million in 2024, then slumped by 72.67% to $1.1 million in 2025.
- The last three Payables figures came in at $1.1 million (Q4 2025), $2.6 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | 921,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 921,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.88 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 821,000.00 |
| Sep 30, 2023 | 1.98 Mn |
| Jun 30, 2023 | 967,000.00 |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 708,000.00 |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 664,000.00 |
| Mar 31, 2022 | 776,000.00 |
| Dec 31, 2021 | 830,000.00 |
| Sep 30, 2021 | 953,000.00 |
| Jun 30, 2021 | 347,000.00 |